# Screening of probiotics for promoting mineral absorption based on in vitro fermentation and cell models

**Authors:** Bin Liu, Yuejian Mao, Jing Yang, Linjun Wu, Xiaoqiong Li, Xiangyu Bian, Jian Kuang, Jianqiang Li, Fangshu Shi, Ying Luo, Peiqing Jiang, Jinjun Li, Haibiao Sun

PMC · DOI: 10.3389/fmicb.2026.1743657 · Frontiers in Microbiology · 2026-02-26

## TL;DR

This study identifies specific probiotic strains that enhance mineral absorption in the gut using in vitro and cell models.

## Contribution

The study systematically evaluates and identifies probiotic strains with the highest potential to improve calcium, iron, and zinc absorption.

## Key findings

- Strains like B. lactis Ca360 and L. plantarum Fe-01 showed high acid production and mineral absorption-promoting abilities.
- B. lactis Ca360 exhibited the best overall performance in promoting calcium, iron, and zinc uptake.
- Phytase activity and SCFA production were key factors in enhancing mineral bioavailability.

## Abstract

Mineral deficiency is a major nutritional issue that threatens human health. Probiotics, owing to their ability to enhance intestinal absorption, are regarded as potential nutritional modulators.

In this study, multiple strains of Lactobacillus and Bifidobacterium were systematically evaluated for their in vitro fermentation metabolism and mineral absorption-promoting properties to screen probiotic candidates possessing mineral uptake-enhancing potential. Eight strains selected via multi-parameter screening were further evaluated for their mineral absorption-promoting capacity using the Caco-2 cell model.

The results revealed significant strain-specific differences in acid production capacity, short-chain fatty acids (SCFAs) generation, and phytase activity. Strains L. paracasei PC-01, B. lactis Ca360, L. plantarum Fe-01, B. lactis MN16620, and L. brevis MN14440 exhibited pronounced acid-producing ability, indicated by markedly decreased fermentation broth pH values. L. reuteri MN11965, L. acidophilus MN06785, L. brevis MN06618, and L. rhamnosus MN08244 showed significantly higher L-lactic acid yields than the positive control. Acetate was the predominant metabolite, followed by propionic and butyric acids, with L. curvatus MN15933, B. lactis Ca360, and B. lactis MN16620 showing particularly strong butyrate production. Phytase activity assays revealed that both intracellular and extracellular enzyme activities of L. plantarum Fe-01 and B. lactis Ca360 were significantly higher than those of L. plantarum 299v. In the Caco-2 cell model, all tested strains significantly increased calcium uptake, with L. plantarum Fe-01 and B. lactis Ca360 showing the highest transmembrane calcium transport efficiency. These two strains also markedly enhanced iron absorption, while B. lactis Ca360 exhibited zinc uptake and transport levels comparable to the positive control.

Comprehensive analysis indicated that strain B. lactis Ca360 demonstrated the most prominent effect in promoting calcium, iron, and zinc absorption, likely through mechanisms involving acid production-induced pH reduction and phytate hydrolysis facilitation. This study provides systematic verification of the integrated mechanisms by which probiotics promote mineral absorption and offers both theoretical support and strain resources for the development of targeted probiotics aimed at improving mineral bioavailability.

## Linked entities

- **Chemicals:** calcium (PubChem CID 5460341), iron (PubChem CID 23925), zinc (PubChem CID 23994), phytate (PubChem CID 890), L-lactic acid (PubChem CID 107689), acetate (PubChem CID 175), propionic acid (PubChem CID 1032), butyric acid (PubChem CID 264)
- **Species:** Lactobacillus acidophilus (taxon 1579)

## Full-text entities

- **Diseases:** anemia (MESH:D000740), neurobehavioral abnormalities (MESH:D019954), immune dysfunction (MESH:D007154), Micronutrient deficiency (MESH:D007153), gastrointestinal discomfort (MESH:D005767), mineral absorption deficiencies (MESH:C564600), nausea (MESH:D009325), inflammatory bowel disease (MESH:D015212), depression (MESH:D003866), obesity (MESH:D009765), constipation (MESH:D003248), colorectal adenoma (MESH:D000236), Calcium deficiency (MESH:D002128), osteoporosis (MESH:D010024), colon adenocarcinoma (MESH:D003110), kidney stones (MESH:D007669), Mineral deficiency (MESH:C537337), gestational hypertension (MESH:D046110), growth disorders (MESH:D006130), Iron deficiency (MESH:D000090463), Zinc deficiency (MESH:C564286), metabolic disorders (MESH:D008659)
- **Chemicals:** STA (MESH:C009695), Fe (MESH:D007501), crotonic acid (MESH:C569473), starch (MESH:D013213), Propionate (MESH:D011422), CaCl2 (MESH:D002122), calcium carbonate (MESH:D002119), EDTA (MESH:D004492), Zinc (MESH:D015032), ZnSO4 (MESH:D019287), PTFE (MESH:D011138), H2 (-), streptomycin (MESH:D013307), molybdenum (MESH:D008982), Ca (MESH:D002118), citrate (MESH:D019343), acid (MESH:D000143), carbon (MESH:D002244), L-LA (MESH:D019344), DPBS (MESH:C012939), CO2 (MESH:D002245), carbohydrate (MESH:D002241), phytate (MESH:D010833), glucose (MESH:D005947), nitrogen (MESH:D009584), mineral (MESH:D008903), oxalate (MESH:D010070), Butyrate (MESH:D002087), Acetate (MESH:D000085), SCFAs (MESH:D005232), isobutyrate (MESH:D058610), valerate (MESH:D014631), ferrous sulfate (MESH:C020748), PBS (MESH:D007854), zinc gluconate (MESH:C030691), penicillin (MESH:D010406), Helium (MESH:D006371), carbonated (MESH:D002254)
- **Species:** Bifidobacterium animalis (species) [taxon 28025], Homo sapiens (human, species) [taxon 9606], Lactobacillus acidophilus (species) [taxon 1579], Lacticaseibacillus rhamnosus (species) [taxon 47715], Lactococcus lactis subsp. lactis (subspecies) [taxon 1360], Latilactobacillus curvatus (species) [taxon 28038], Lactococcus lactis (species) [taxon 1358], Lactiplantibacillus plantarum (species) [taxon 1590], Glycine max (soybean, species) [taxon 3847], Lacticaseibacillus paracasei (species) [taxon 1597], Limosilactobacillus reuteri (species) [taxon 1598], Lactobacillus helveticus (species) [taxon 1587], Latilactobacillus sakei (species) [taxon 1599], Bifidobacterium (genus) [taxon 1678], Levilactobacillus brevis (species) [taxon 1580], Limosilactobacillus fermentum (species) [taxon 1613]
- **Cell lines:** MN16620 — Homo sapiens (Human), Transformed cell line (CVCL_GM58), -2 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_A628), Ca360 — Homo sapiens (Human), Lung small cell carcinoma, Cancer cell line (CVCL_A557), Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12979561/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12979561/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12979561/full.md

---
Source: https://tomesphere.com/paper/PMC12979561